Bulletin from the Extraordinary General Meeting of Dignitana AB (publ)

The following resolutions were passed at the Extraordinary General Meeting (the “EGM”) of Dignitana AB (publ) (the “Company”) on 5 June 2025 in Lund.

Board of Directors

The EGM resolved, in accordance with the proposal from the shareholder Paxman AB (publ), that the Board of Directors shall consist of three ordinary members with no deputy Board members. Furthermore, the EGM resolved to dismiss the Board members Klas Arildsson, Richard DiIorio, Lina Karlsson, Fredrik Lindgren, and Hope S. Rugo, MD. The EGM also resolved to elect Per-Anders Johansson, Richard Paxman, and Emelie Gustafsson as Board members for the period until the end of the next Annual General Meeting. Per-Anders Johansson was elected as Chairman of the Board.

For More Information Contact 

Melissa Bourestom, Chief Communications Officer,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is a Swedish medical technology company specializing in scalp cooling. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.

Tags: